Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guosheng Fu

Showing results (281-290 of 290) with videos related to

Pageof 29
Sort By:
You have reached the last page of results.This site can display upto 290 results.
Journal of the American College of Cardiology|November 24, 2022
2-Year Outcomes of Angiographic Quantitative Flow Ratio-Guided Coronary InterventionsLei Song, Bo Xu, Shengxian Tu, et al.
Clinical Cardiology|October 15, 2021
Lipid goal attainment in post-acute coronary syndrome patients in China: Results from the 6-month real-world dyslipidemia international study IIYanjun Gong, Xuan Li, Xiang Ma, et al.
Scientific Reports|March 11, 2018
Evaluation of the therapeutic effects of QuickOpt optimization in Chinese patients with chronic heart failure treated by cardiac resynchronizationJi Yan, Shu Zhang, Dejia Huang, et al.
Circulation|June 9, 2021
PKM1 Exerts Critical Roles in Cardiac Remodeling Under Pressure Overload in the HeartQinfeng Li, Chao Li, Abdallah Elnwasany, et al.
Lancet (London, England)|November 7, 2021
Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trialBo Xu, Shengxian Tu, Lei Song, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|September 5, 2023
Efficacy and safety of olmesartan medoxomil-amlodipine besylate tablet in Chinese patients with essential hypertension: A prospective, single-arm, multi-center, real-world studyZhaoqiang Cui, Zhaohui Qiu, Wenli Cheng, et al.
Experimental and Therapeutic Medicine|January 18, 2024
Efficacy and safety of olmesartan medoxomil‑amlodipine besylate tablets (Sevikar<sup>®</sup>) in older patients with essential hypertension: Subgroup analysis from the Sevikar studyZhaoqiang Cui, Zhaohui Qiu, Wenli Cheng, et al.
Pacing and Clinical Electrophysiology : PACE|August 12, 2023
Chinese expert consensus on the construction of the fluoroless cardiac electrophysiology laboratory and related techniquesChenyang Jiang, Changsheng Ma, Songwen Chen, et al.
Circulation|March 19, 2026
Memantine for Premature Atrial Contractions: A Phase 2 Randomized Clinical TrialYunli Shen, Chunyu Zeng, Yingxian Sun, et al.
Cardiology Plus|July 24, 2023
2023 Chinese expert consensus on the impact of COVID-19 on the management of cardiovascular diseasesFeng Bai, Jun Pu, Wenliang Che, et al.
Pageof 29

Showing results (281-290 of 290) with videos related to

Sort By:
Pageof 29
You have reached the last page of results.This site can display upto 290 results.
Journal of the American College of Cardiology|November 24, 2022
2-Year Outcomes of Angiographic Quantitative Flow Ratio-Guided Coronary InterventionsLei Song, Bo Xu, Shengxian Tu, et al.
Clinical Cardiology|October 15, 2021
Lipid goal attainment in post-acute coronary syndrome patients in China: Results from the 6-month real-world dyslipidemia international study IIYanjun Gong, Xuan Li, Xiang Ma, et al.
Scientific Reports|March 11, 2018
Evaluation of the therapeutic effects of QuickOpt optimization in Chinese patients with chronic heart failure treated by cardiac resynchronizationJi Yan, Shu Zhang, Dejia Huang, et al.
Circulation|June 9, 2021
PKM1 Exerts Critical Roles in Cardiac Remodeling Under Pressure Overload in the HeartQinfeng Li, Chao Li, Abdallah Elnwasany, et al.
Lancet (London, England)|November 7, 2021
Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trialBo Xu, Shengxian Tu, Lei Song, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|September 5, 2023
Efficacy and safety of olmesartan medoxomil-amlodipine besylate tablet in Chinese patients with essential hypertension: A prospective, single-arm, multi-center, real-world studyZhaoqiang Cui, Zhaohui Qiu, Wenli Cheng, et al.
Experimental and Therapeutic Medicine|January 18, 2024
Efficacy and safety of olmesartan medoxomil‑amlodipine besylate tablets (Sevikar<sup>®</sup>) in older patients with essential hypertension: Subgroup analysis from the Sevikar studyZhaoqiang Cui, Zhaohui Qiu, Wenli Cheng, et al.
Pacing and Clinical Electrophysiology : PACE|August 12, 2023
Chinese expert consensus on the construction of the fluoroless cardiac electrophysiology laboratory and related techniquesChenyang Jiang, Changsheng Ma, Songwen Chen, et al.
Circulation|March 19, 2026
Memantine for Premature Atrial Contractions: A Phase 2 Randomized Clinical TrialYunli Shen, Chunyu Zeng, Yingxian Sun, et al.
Cardiology Plus|July 24, 2023
2023 Chinese expert consensus on the impact of COVID-19 on the management of cardiovascular diseasesFeng Bai, Jun Pu, Wenliang Che, et al.
Pageof 29